KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 09, 2026 >>  ABB India 6776.25  [ 0.09% ]  ACC 1133.45  [ 0.25% ]  Ambuja Cements 350  [ 2.34% ]  Asian Paints 2345  [ 0.95% ]  Axis Bank 1259  [ 0.96% ]  Bajaj Auto 9787  [ 1.42% ]  Bank of Baroda 236  [ 0.81% ]  Bharti Airtel 1806.6  [ 0.57% ]  Bharat Heavy 432.8  [ 0.53% ]  Bharat Petroleum 287.4  [ 0.24% ]  Britannia Industries 4821  [ 1.33% ]  Cipla 1303.3  [ -0.13% ]  Coal India 410.9  [ 0.69% ]  Colgate Palm 1820.1  [ 4.60% ]  Dabur India 386.1  [ 2.41% ]  DLF 646.5  [ 1.60% ]  Dr. Reddy's Lab. 1195.1  [ 1.28% ]  GAIL (India) 166.85  [ 0.09% ]  Grasim Industries 2895  [ 1.05% ]  HCL Technologies 1214.3  [ 2.84% ]  HDFC Bank 707.1  [ 2.09% ]  Hero MotoCorp 4909  [ 1.01% ]  Hindustan Unilever 1861  [ 1.02% ]  Hindalco Industries 899.2  [ 0.67% ]  ICICI Bank 1354.1  [ 0.01% ]  Indian Hotels Co. 715.3  [ 0.32% ]  IndusInd Bank 862.45  [ -0.34% ]  Infosys 1024.05  [ 3.01% ]  ITC 266.2  [ 4.78% ]  Jindal Steel 1015.7  [ 0.56% ]  Kotak Mahindra Bank 440.1  [ 0.32% ]  L&T 3699.1  [ 2.17% ]  Lupin 1960  [ 0.93% ]  Mahi. & Mahi 2792.1  [ 0.80% ]  Maruti Suzuki India 11395  [ 1.54% ]  MTNL 22.92  [ 0.53% ]  Nestle India 1333.1  [ 0.99% ]  NIIT 82.11  [ 0.27% ]  NMDC 71.96  [ 1.64% ]  NTPC 311.1  [ 0.58% ]  ONGC 221.1  [ 1.19% ]  Punj. NationlBak 116.8  [ 1.13% ]  Power Grid Corpn. 249.5  [ 1.67% ]  Reliance Industries 1170.8  [ -0.55% ]  SBI 958.1  [ 1.86% ]  Vedanta 263.5  [ 4.11% ]  Shipping Corpn. 277.45  [ -1.32% ]  Sun Pharmaceutical 1756.9  [ 0.25% ]  Tata Chemicals 589.8  [ -0.46% ]  Tata Consumer 953.1  [ 0.22% ]  Tata Motors Passenge 279.1  [ 2.14% ]  Tata Steel 173.6  [ 1.22% ]  Tata Power Co. 341.95  [ 1.92% ]  Tata Consult. Serv. 2163  [ 4.23% ]  Tech Mahindra 1517.05  [ 1.43% ]  UltraTech Cement 10680  [ 2.05% ]  United Spirits 1359.55  [ 3.51% ]  Wipro 162.7  [ 2.59% ]  Zee Entertainment 70.09  [ 2.52% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    SYNCOM FORMULATION (INDIA) LTD.

    09 October 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE312C01025 BSE Code / NSE Code 524470 / SYNCOMF Book Value (Rs.) 4.68 Face Value 1.00
    Bookclosure 23/09/2026 52Week High 27 EPS 0.81 P/E 28.63
    Market Cap. 2188.32 Cr. 52Week Low 10 P/BV / Div Yield (%) 4.98 / 0.43 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Syncom Formulation (India) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Syncom Formulation (India) Ltd. 124.66 134.00 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Syncom Formulation (India) Ltd. 7.82 14.23 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Syncom Formulation (India) Ltd. 24.32 19.00 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Syncom Formulation (India) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Syncom Formulation (India) Ltd. 24.59 24.57 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Syncom Formulation (India) Ltd. 94.00 94.00 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Syncom Formulation (India) Ltd. 19.51 14.18 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Syncom Formulation (India) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Syncom Formulation (India) Ltd. 19.72 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Syncom Formulation (India) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Syncom Formulation (India) Ltd. 486.57 462.85 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Syncom Formulation (India) Ltd. 77.16 53.51 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Syncom Formulation (India) Ltd. 30.97 17.19 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Syncom Formulation (India) Ltd. 100.49 64.65 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Syncom Formulation (India) Ltd. 76.01 48.87 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Syncom Formulation (India) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Syncom Formulation (India) Ltd. 94.00 94.00 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Syncom Formulation (India) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Syncom Formulation (India) Ltd. 318.30 245.90 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Syncom Formulation (India) Ltd. 0.68 4.04 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Syncom Formulation (India) Ltd. 116.27 65.74 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Syncom Formulation (India) Ltd. 183.51 124.91 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Syncom Formulation (India) Ltd. 109.08 92.86 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Syncom Formulation (India) Ltd. 236.67 191.91 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Syncom Formulation (India) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Syncom Formulation (India) Ltd. 15.85 11.55 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Syncom Formulation (India) Ltd. 15.62 10.55 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Syncom Formulation (India) Ltd. 0.80 0.51 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Syncom Formulation (India) Ltd. 18.43 14.37 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Syncom Formulation (India) Ltd. 0.00 0.01 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Syncom Formulation (India) Ltd. 97.87 83.15 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Syncom Formulation (India) Ltd. 2.04 2.92 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Syncom Formulation (India) Ltd. 0.10 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute